Astek Diagnostics
Astek Diagnostics is a precision diagnostics company dedicated to developing rapid, point-of-care infection detection and antibiotic sensitivity testing solutions. Their flagship product, the Jiddu Platform, aims to revolutionize the diagnosis and treatment of bacterial infections across multiple sample types, including urine, CSF, effluent, and blood. The company is focused on bringing a highly accurate, one-hour UTI diagnostic test to market in 2025, supported by collaborations with leading healthcare institutions, grants, and strategic partnerships. Their mission is to improve patient outcomes, reduce healthcare costs, and combat antimicrobial resistance through innovative diagnostic technology.
Industries
Nr. of Employees
small (1-50)
Products
Benchtop point-of-care analyzer with disposable microfluidic cartridges for rapid AST
A benchtop diagnostic system that processes biofluid samples via disposable microfluidic cartridges, isolates bacteria, performs short-term microculture with antibiotic exposures, and reports infection status and antibiotic susceptibility indications in about one hour.
Benchtop point-of-care analyzer with disposable microfluidic cartridges for rapid AST
A benchtop diagnostic system that processes biofluid samples via disposable microfluidic cartridges, isolates bacteria, performs short-term microculture with antibiotic exposures, and reports infection status and antibiotic susceptibility indications in about one hour.
Services
Clinical pilot studies and validation partnerships
Design and conduct of blinded pilot and feasibility studies in collaboration with hospitals and research institutes to compare rapid AST platform outputs against laboratory culture and sensitivity results.
Early access deployment and data collection program
Provision of analyzer units and cartridges to strategic clinical partners under early access agreements to collect deployment and performance data prior to regulatory clearance.
Manufacturing design acceleration using AI/ML
Application of machine learning and LLM-based tools to accelerate microfluidic device design iterations and reduce manufacturing cycle time and cost.
Clinical pilot studies and validation partnerships
Design and conduct of blinded pilot and feasibility studies in collaboration with hospitals and research institutes to compare rapid AST platform outputs against laboratory culture and sensitivity results.
Early access deployment and data collection program
Provision of analyzer units and cartridges to strategic clinical partners under early access agreements to collect deployment and performance data prior to regulatory clearance.
Manufacturing design acceleration using AI/ML
Application of machine learning and LLM-based tools to accelerate microfluidic device design iterations and reduce manufacturing cycle time and cost.
Expertise Areas
- Point-of-care diagnostic development
- Rapid antibiotic susceptibility testing (AST)
- Microfluidics design and cartridge development
- Fluorescence-based metabolic assay development
Key Technologies
- Microfluidic cartridge-based sample processing
- Fluorescence metabolic viability assay (resazurin/resorufin chemistry)
- Benchtop point-of-care analyzer hardware
- Single-excitation/single-emission fluorometry